Kane Biotech Inc. (KNBIF)

Kane Biotech Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.54	0.75	1.1	1.15	1.01	0.83
Cash & Short-Term Investments	0.54	0.75	1.1	1.15	1.01	0.83
Cash Growth	-66.46%	-32.19%	-4.18%	14.40%	20.84%	1005.90%
Accounts Receivable	0.34	0	0.32	0.18	0.29	0.33
Other Receivables	0.44	0.1	0.74	0.89	0.82	0.03
Receivables	0.79	0.1	1.06	1.07	1.12	0.36
Inventory	0.69	0.25	0.76	0.52	0.47	0.59
Other Current Assets	0.19	2.62	0.17	0.14	0.14	0.06
Total Current Assets	2.21	3.72	3.1	2.88	2.74	1.84
Property, Plant & Equipment	0.97	1.07	1.25	1.44	0.16	0.08
Other Intangible Assets	0.73	0.73	0.83	0.83	0.78	0.77
Other Long-Term Assets	-	0.16	0.44	0.86	1.25	-
Total Assets	3.91	5.68	5.62	6.13	5.04	2.76
Accounts Payable	0.7	0.44	0.6	0.63	0.66	0.51
Short-Term Debt	0.01	6.63	4.01	2.39	1.53	0.04
Current Portion of Long-Term Debt	0.33	0.34	0.17	-	-	-
Current Portion of Leases	0.12	0.11	0.1	0.13	0.05	0.01
Current Unearned Revenue	-	0.75	0.21	0.14	0.07	0.07
Other Current Liabilities	1.6	2.62	1.24	1.43	0.61	0.72
Total Current Liabilities	2.76	10.89	6.34	4.72	2.92	1.34
Long-Term Debt	1.05	1.3	1.6	1.12	0.66	0.15
Long-Term Leases	0.79	0.87	0.98	1.09	0.03	0.01
Long-Term Unearned Revenue	-	0.19	0.84	0.78	0.35	0.41
Other Long-Term Liabilities	-	0.83	-	-	-	-
Total Liabilities	4.59	14.09	9.76	7.7	3.96	1.92
Common Stock	24.38	23.69	23.13	22.16	20.86	20.16
Additional Paid-In Capital	8.2	7.75	7.44	5.51	4.41	3.95
Retained Earnings	-33.33	-42.13	-37.1	-33.21	-28.61	-24.89
Comprehensive Income & Other	0.07	0.14	-	1.66	1.84	1.61
Total Common Equity	-0.69	-10.56	-6.52	-3.89	-1.49	0.84
Minority Interest	-	2.15	2.38	2.32	2.56	-
Shareholders' Equity	-0.69	-8.41	-4.14	-1.57	1.07	0.84
Total Liabilities & Equity	3.91	5.68	5.62	6.13	5.04	2.76
Total Debt	2.29	9.26	6.86	4.72	2.27	0.21
Net Cash (Debt)	-1.75	-8.51	-5.76	-3.57	-1.26	0.62
Net Cash Per Share	-0.01	-0.07	-0.05	-0.03	-0.01	0.01
Filing Date Shares Outstanding	137.51	131.84	124.85	114.83	108.61	108.61
Total Common Shares Outstanding	137.51	131.84	124.83	114.81	108.61	101.53
Working Capital	-0.55	-7.17	-3.24	-1.84	-0.19	0.5
Book Value Per Share	-0.01	-0.08	-0.05	-0.03	-0.01	0.01
Tangible Book Value	-1.42	-11.29	-7.35	-4.71	-2.27	0.07
Tangible Book Value Per Share	-0.01	-0.09	-0.06	-0.04	-0.02	0.00
Machinery	0.42	0.4	0.51	0.47	0.28	0.25

Updated Nov 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.